Skip to main content
GKB logo

GKB — Investor Relations & Filings

Ticker · 1707 ISIN · TW0001707008 TW Manufacturing
Open in API
Filings indexed 2,128 across all filing types
Latest filing 2024-01-08 Regulatory Filings
Country TW Taiwan
Listing TW 1707

About GKB

http://www.grapeking.com.tw

Grape King Bio Ltd. is a biotechnology firm specializing in the research, development, and production of health supplements and functional beverages. Established in 1969, the company has evolved into a prominent provider of probiotics, energy drinks, and nutritional products tailored for diverse age groups. It operates a dedicated Biotech Research Institute staffed by over 160 specialists, focusing on proprietary fermentation technology and innovative formulations that have garnered over 170 international awards. The company offers a comprehensive one-stop OEM/ODM platform, providing integrated manufacturing services across various dosage forms. Guided by the philosophy of "Technology, Health, and Hope," Grape King Bio serves global markets through its own brands and strategic subsidiaries, emphasizing high-quality standards and advanced biotechnological applications to enhance consumer well-being.

Recent filings

Filing Released Lang Actions
112年12月營業收入
Regulatory Filings Classification · 95% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 葡萄王 (Grape King) for the month of December in the 112th year of the Republic of China calendar (equivalent to 2023). It includes comparative figures from the previous year and percentage changes. The document is very short (778 characters) and contains no detailed financial statements, management discussion, or comprehensive analysis. It appears to be a brief financial data disclosure rather than a full report. There is no indication that this is an earnings release (which typically highlights key financial results with narrative), nor is it a full interim or annual report. It is also not a regulatory filing announcing a report or a certification. Given the nature of the data (monthly revenue summary) and the brevity, this fits best as a Regulatory Filing (RNS) which is a general category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-01-08 Chinese
112年12月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, general managers, and other executives, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on insider share ownership and transactions, which aligns with reporting requirements for insider dealings. There is no indication of financial statements, earnings data, meeting materials, or other report types. The document is not a brief announcement but a detailed disclosure of insider shareholdings. Therefore, the document fits the category of Director's Dealing (DIRS).
2024-01-05 Chinese
112年12月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors and senior management, showing their current and initial shareholdings, pledged shares, and related information. It lists individual names, titles, and share counts, which is characteristic of insider shareholding disclosures. There is no indication of financial statements, earnings data, or meeting materials. The document is not a report or announcement of a report but a direct disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is short (2880 characters), consistent with a shareholding notification rather than a full report. Therefore, the appropriate classification is DIRS with high confidence.
2024-01-05 Chinese
112年12月法人說明會簡報 — 170720231207E001.pdf
Regulatory Filings
2023-12-07 Chinese
112年12月法人說明會簡報 — 170720231207M001.pdf
Regulatory Filings
2023-12-07 Chinese
112年12月法人說明會簡報
Investor Presentation Classification · 95% confidence The document is a listing from a public information observation station showing details about a scheduled or held investor presentation (法人說明會 translates to 'investor presentation' or 'analyst meeting'). It includes company code, name, date, time, location, summary information, and links to presentation materials. The document is short (690 characters) and primarily provides information about an investor presentation event rather than a full report or financial data. Therefore, it fits the category of Investor Presentation (IP).
2023-12-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.